Tag Archives: Barron039s

Exxon Mobil Stock Rises on Earnings. CEO Cites Highest Upstream Production in 25 Years. – Barron's

Exxon Mobil Stock Rises on Earnings. CEO Cites Highest Upstream Production in 25 Years.  Barron’s Exxon earnings beat estimates as production growth softens impact of lower oil prices  CNBC ExxonMobil announces second-quarter 2025 results  Exxon Mobil Corporation Exxon Chief Says Demand for Oil Remains ‘Very, Very Strong.’  The New York Times Exxon, Chevron profits to drop to lowest point since pandemic, analysts say  Yahoo Finance …

Read More »

AbbVie Stock Pops After Earnings. What’s Driving Shares Higher. – Barron's

AbbVie Stock Pops After Earnings. What’s Driving Shares Higher.  Barron’s AbbVie sees no outsized tariff exposure, boosts profit forecast  Yahoo Finance AbbVie in charts: Revenues from Humira -58%, Skyrizi +62%, Rinvoq +42% Y/Y (ABBV:NYSE)  Seeking Alpha Is ABBV Stock (ABBV) a Buy Ahead of Q2 Earnings?  TipRanks Why AbbVie Stock Slumped Today  The Motley Fool Source link

Read More »

Cigna Stock Falls on Earnings Even as It Sidesteps the Managed-Care Crisis – Barron's

Cigna Stock Falls on Earnings Even as It Sidesteps the Managed-Care Crisis  Barron’s Cigna (CI) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates  Yahoo Finance Cigna affirms outlooks as Evernorth Health Services drives growth  Modern Healthcare Cigna Profits Hit $1.5 Billion Despite Higher Costs  Forbes Wells Fargo surprised to see Cigna stock weaker following pullback  TipRanks Source link

Read More »

MicroStrategy Beats Earnings Estimates. The Stock Rises. – Barron's

MicroStrategy Beats Earnings Estimates. The Stock Rises.  Barron’s Top analyst warns on MicroStrategy results ahead of earnings  Yahoo Finance Strategy Announces Second Quarter 2025 Financial Results  Strategy MicroStrategy Swings to Profit on Bitcoin Gains  The Wall Street Journal MicroStrategy just posted a huge profit. It’s the second time riding on an accounting rule change.  MarketWatch Source link

Read More »

Trump Talks Tough on Drug Prices but His Demands Have Softened – Barron's

Trump Talks Tough on Drug Prices but His Demands Have Softened  Barron’s Trump Demands That Drugmakers Lower Some of Their U.S. Prices by September  The New York Times Trump threatens drug giants with crackdown over prices  The Guardian Trump calls for price cuts on prescription drugs within 60 days in letters to Eli Lilly, Pfizer, other drugmakers  NBC News Trump sends letters to 17 …

Read More »

Reddit Stock Jumps 15% as Earnings Beat Estimates and Revenue Soars – Barron's

Reddit Stock Jumps 15% as Earnings Beat Estimates and Revenue Soars  Barron’s Reddit shares jump as much as 20% on second-quarter sales and guidance beat  CNBC Reddit Stock Surges Higher on Strong Advertising Projections  Bloomberg.com Reddit forecasts strong revenue on AI-driven ad strength, shares surge  Reuters Reddit set to report Q2 earnings as Wall Street scrutinizes daily active user growth  Yahoo Finance Source link

Read More »

Why Copper Prices Are Falling After Trump’s 50% Tariff Order – Barron's

Why Copper Prices Are Falling After Trump’s 50% Tariff Order  Barron’s Trump slaps universal 50% tariff on copper imports; metal’s price plunges  CNBC How Trump’s Copper Tariffs Surprise Shook the Market  Bloomberg.com Trump issues blitz of tariff announcements on copper, Brazil, South Korea, small-value imports  Reuters ADJUSTING IMPORTS OF COPPER INTO THE UNITED STATES  The White House (.gov) Source link

Read More »

Meta Stock: Facebook Parent Surges Near Record High. Everything to Know About Its Blowout Earnings. – Barron's

Meta Stock: Facebook Parent Surges Near Record High. Everything to Know About Its Blowout Earnings.  Barron’s Meta Shares Soar as Ad Business Continues to Fuel AI Ambitions  The Wall Street Journal Meta’s growth strikes Wall Street as incomprehensibly strong, and the stock rockets  MarketWatch ‘Superintelligence’ Will Create a New Era of Empowerment, Mark Zuckerberg Says  The New York Times Meta Reports Second Quarter 2025 …

Read More »

Elli Lilly Weight-Loss Drug Makes Cardio Advance. More Bad News for Novo Nordisk. – Barron's

Elli Lilly Weight-Loss Drug Makes Cardio Advance. More Bad News for Novo Nordisk.  Barron’s Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease  Eli Lilly and Company Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity  CNBC Eli Lilly’s diabetes …

Read More »